Will the Avacta share price keep climbing?

The Avacta share price could continue to move higher if the company reports substantial operational progress in the next few months.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Avacta (LSE: AVCT) share price has been one of the market’s best-performing investments over the past 12 months. The stock has risen a staggering 970% since the end of March last year.

While past performance should never be used as a guide to future potential, I’ve wondered if it’s too late to invest in the stock following this performance. It’s clear the company has potential, but I’m worried I might have missed the boat. 

The Avacta share price outlook 

Last year, Avacta became one of the many small healthcare and diagnostic businesses that tried to use their knowledge to design a rapid Covid-19 test. 

The company partnered with Cytiva to develop the test and, by August, the business had a product ready for clinical trials. According to preliminary trial results released in January, the test had an accuracy rating of 96.7% in identifying Covid-19 infections.

Based on these results, the organisation is now pursuing full clinical approval to launch its test in Europe.

If the company receives approval, the opportunity could be tremendous. The UK alone is carrying out over one million coronavirus test every day. This suggests the demand for tests is running at around 365m a year, but that’s only the UK. Throw in Europe as well, and the number could be over a billion. 

This market potential seems to be behind the recent performance of the Avacta share price. If the group can grab just a sliver of this market, the rewards could be substantial.

Risks and challenges

Unfortunately, as the group’s test is yet to be approved, it’s almost impossible to tell what the future holds for the business. We don’t know how enormous the market potential could ultimately be, and there’s no guarantee the test will ever hit the market.

What’s more, Avacta is just one fish in a big pond. It will have to compete with the likes of Swiss pharmaceutical giant Roche for market share in the testing market. 

Considering these risks and challenges, I’m not in any rush to add the Avacta share price to my portfolio. I think the business could have potential. But, until we have more idea of how the company’s ambitions will translate into cold, hard cash, it’s difficult to argue that the stock is worth its current valuation.

Indeed, at the time of writing, the company has a market capitalisation of just over £600m. That’s a lot of money for a business with virtually no revenue and reported operating losses of £8.1m for 2020, up from £6.6m in 2019. 

That said, the business could prove me wrong. I think the Avacta share price is far too expensive at current levels, but all it could take is a significant contract award, or agreement with a country’s health service, and its outlook would change entirely. 

In this scenario, the Avacta share price could keep climbing. However, without further operational progress, it may struggle to move higher.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »